Mondrian Investment Partners LTD - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Mondrian Investment Partners LTD ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$45,000
-98.9%
1,401
-99.0%
0.00%
-98.8%
Q4 2021$4,092,000
+9.3%
140,3340.0%0.08%
+6.6%
Q3 2021$3,743,000
+30.6%
140,334
+50.7%
0.08%
+38.2%
Q2 2021$2,867,000
+1.1%
93,1050.0%0.06%
-9.8%
Q1 2021$2,835,00093,1050.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders